{"id": "1118684331348832262", "creation": 1555550103.0, "user_id": "442982534", "social_network": "twitter", "nsfw": false, "request": ["d47670bd-00d9-4b4b-b654-af12857ee504"], "metrics": {"d47670bd-00d9-4b4b-b654-af12857ee504": {"retweet_count": 2, "reply_count": 0, "like_count": 7, "quote_count": 0}}, "text": "Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial: https://t.co/zPpjThS1SD\n\nCalling this latest development \"excellent news,\" Paradigm Capital has raised its target price on the company's stock. \n\n$TBP.CA #cannabis #cancer #healthcare #stocks @TetraBioPharma https://t.co/DXB1QGsPXE", "first_save": 1635509975.555947, "hashtags": ["#CANNABIS", "#CANCER", "#HEALTHCARE", "#STOCKS"]}